In terms of individual MS-related metabolic abnormalities, the relationship between decreased SOD activity and elevated TG, obesity, and central obesity was merely mediated by insulin resistance, whereas the contribution of decreased SOD activity to elevated postload blood glucose was merely mediated by β-cell dysfunction. Here, SOD1 is linked to obesity disorder.